'Gondola' is the medical device that improves the walking of patients suffering from Parkinson. By activating the brain areas responsible for movement with the technique of peripheral automatic mechanical stimulation (Automated Mechanical Peripheral Stimulation, AMPS) whose effectiveness has been proven by various clinical studies such as the one published in the journal PlosOne by some researchers including Dr. Carlo Quattrocchi, manager ofDiagnostic Imaging Unit of the Campus Bio-Medico University Hospital, under the coordination of the Center for the treatment and diagnosis of Parkinson's of the IRCCS San Raffaele in Rome. A work that demonstrates how AMPS determines a greater activation of the brain regions involved in movement management and in the analysis of the surrounding space.
“Peripheral automatic mechanical stimulation - comments Carlo Four eyes - it has an effect on those brain areas that are usually recruited in parkinsonian patients to compensate for the deficits resulting from the disease. After a singStimulation improves walking speed, balance and cadence of steps. It remains to be demonstrated which Parkinson's patients can benefit most from this therapy and the duration of the effects observed on motor symptoms.".
A challenge taken up by one new trial that will start in 2017 and will involve 160 patients, with the contribution, in this case, of the Neurology Unit ofUniversità Campus Bio-Medico di Roma. The research, which involves 2 cycles of 6 stimulations carried out with the 'Gondola' device for each patient enrolled, will be conducted by the University of Health Sciences of Porto Alegre, together with Irccs San Raffaele Pisana of Rome and the Department of Neurorehabilitative Sciences - Casa di cured by the Milan Polyclinic. For UCBM will be Prof. Vincenzo Di Lazzaro, Professor of Neurology, with the collaboration of neurologists Lucia Florio e Lazzaro di Biaseto coordinate the project.